Alpha Innotech Enters into Licensing and Supply Agreement with GE Healthcare
News Jan 20, 2006
Under the terms of the agreement, Alpha Innotech will bundle ArrayVision™ software for microarray analysis with its multiplex array detection system, NovaRay™, laser scanning system.
"Our agreement with GE Healthcare enables us to combine one of the best array analysis software packages available on the market with our state of the art instruments, providing our customers with a complete solution for their microarray experiments," said Sia Ghazvini, vice president of business development for Alpha Innotech.
ArrayVision is designed with maximum flexibility to suit the needs of any size lab and uses configurable protocols to suit any array format.
The incorporated Protein Analysis module analyzes protein/multiplex arrays in microplates and on slides.
Protein concentrations can be quantified using standard curves derived from any number of reference proteins.
Quality control functions enable users to identify and rapidly remove outliers for improved data quality.
A simple export function creates a customized Excel worksheet displaying an easy to comprehend summary of raw data, curve fits and calibrated data.
The protein analysis utility adds to the power and scope of ArrayVision, which is already recognized as one of the most flexible microarray software solutions.
"ArrayVision’s flexible design will provide broad image analysis support for NovaRay users. We are happy to combine these two powerful tools to provide customers with a comprehensive and effective systems solution," said Keiko Hattori, head of marketing for GE Healthcare, Discovery Systems.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.